IGC Pharma

IGCNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$29.464 M

$0.29 +6.98%

Close of 18 Sept 2026

Revenue

$1.27M

#3465 by revenue

Earnings

-$7.12M

Loss-making

Shares outstanding

103,384,008

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#377China PharmaCPHI$30.5M
#378Quantum BiopharmaQNTM$29.6M
#379IGC PharmaIGC$29.5M
#380Kyntra BioKYNB$28.6M
#381Optimi HealthOPTH$28.3M

What if IGC Pharma were worth as much as…

Open the what-if tool →

Gold $30.4T

$293,928.04

Per share 1,031,326× higher

Bitcoin $1.64T

$15,824.77

Per share 55,526× higher

Nvidia $5.36T

$51,813.69

Per share 181,802× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for IGC Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.